153 related articles for article (PubMed ID: 24275104)
1. Impact of clinical inertia on cardiovascular risk factors in patients with diabetes.
Whitford DL; Al-Anjawi HA; Al-Baharna MM
Prim Care Diabetes; 2014 Jul; 8(2):133-8. PubMed ID: 24275104
[TBL] [Abstract][Full Text] [Related]
2. Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
März W; Dippel FW; Theobald K; Gorcyca K; Iorga ŞR; Ansell D
Atherosclerosis; 2018 Jan; 268():99-107. PubMed ID: 29197254
[TBL] [Abstract][Full Text] [Related]
3. Suboptimal control of lipid levels: results from the non-interventional Centralized Pan-Russian Survey of the Undertreatment of Hypercholesterolemia II (CEPHEUS II).
Boytsov S; Logunova N; Khomitskaya Y;
Cardiovasc Diabetol; 2017 Dec; 16(1):158. PubMed ID: 29246151
[TBL] [Abstract][Full Text] [Related]
4. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
Kuznik A; Mardekian J
Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
[TBL] [Abstract][Full Text] [Related]
5. Extent of undertreatment and overtreatment with cholesterol-lowering therapy according to European guidelines in 92,348 Danes without ischemic cardiovascular disease and diabetes in 2004-2014.
Langsted A; Freiberg JJ; Nordestgaard BG
Atherosclerosis; 2017 Feb; 257():9-15. PubMed ID: 28038381
[TBL] [Abstract][Full Text] [Related]
6. Change in cardiovascular risk factors in relation to diabetes status: the Tromso Study.
Joseph J; Svartberg J; Njølstad I; Schirmer H
Eur J Prev Cardiol; 2012 Jun; 19(3):551-7. PubMed ID: 21505026
[TBL] [Abstract][Full Text] [Related]
7. A retrospective, cross-sectional study of real-world values of cardiovascular risk factors using a healthcare database in Japan.
Shima D; Ii Y; Yamamoto Y; Nagayasu S; Ikeda Y; Fujimoto Y
BMC Cardiovasc Disord; 2014 Sep; 14():120. PubMed ID: 25231128
[TBL] [Abstract][Full Text] [Related]
8. Sex disparity persists in the prevention of cardiovascular disease in women on statin therapy compared to that in men.
Moreno-Arellano S; Delgado-de-Mendoza J; Santi-Cano MJ
Nutr Metab Cardiovasc Dis; 2018 Aug; 28(8):810-815. PubMed ID: 29754716
[TBL] [Abstract][Full Text] [Related]
9. Diabetes care and complications in primary care in the Tshwane district of South Africa.
Webb EM; Rheeder P; Van Zyl DG
Prim Care Diabetes; 2015 Apr; 9(2):147-54. PubMed ID: 24933340
[TBL] [Abstract][Full Text] [Related]
10. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
[TBL] [Abstract][Full Text] [Related]
11. Variation in Lipid-Lowering Therapy Use in Patients With Low-Density Lipoprotein Cholesterol ≥190 mg/dL: Insights From the National Cardiovascular Data Registry-Practice Innovation and Clinical Excellence Registry.
Virani SS; Kennedy KF; Akeroyd JM; Morris PB; Bittner VA; Masoudi FA; Stone NJ; Petersen LA; Ballantyne CM
Circ Cardiovasc Qual Outcomes; 2018 May; 11(5):e004652. PubMed ID: 29748356
[TBL] [Abstract][Full Text] [Related]
12. Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice.
Faggiano P; Fattirolli F; Frisinghelli A; Piccioli L; Dasseni N; Silverii MV; Albricci L; D'Ambrosio G; Garrì R; Esposito L; Giallauria F
Monaldi Arch Chest Dis; 2019 May; 89(2):. PubMed ID: 31107039
[TBL] [Abstract][Full Text] [Related]
13. Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.
Eder S; Leierer J; Kerschbaum J; Rosivall L; Wiecek A; de Zeeuw D; Mark PB; Heinze G; Rossing P; Heerspink HL; Mayer G
Diab Vasc Dis Res; 2019 Jan; 16(1):47-56. PubMed ID: 30238781
[TBL] [Abstract][Full Text] [Related]
14. An intensive follow-up in subjects with cardiometabolic high-risk.
Pérez HA; Adeoye AO; Aballay L; Armando LA; García NH
Nutr Metab Cardiovasc Dis; 2021 Sep; 31(10):2860-2869. PubMed ID: 34353703
[TBL] [Abstract][Full Text] [Related]
15. Implications of American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Guidelines on Statin Underutilization for Prevention of Cardiovascular Disease in Diabetes Mellitus Among Several US Networks of Community Health Centers.
Akhabue E; Rittner SS; Carroll JE; Crawford PM; Dant L; Laws R; Leo MC; Puro J; Persell SD
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28673901
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States.
Lu Y; Wang P; Zhou T; Lu J; Spatz ES; Nasir K; Jiang L; Krumholz HM
J Am Heart Assoc; 2018 Jan; 7(3):. PubMed ID: 29374046
[TBL] [Abstract][Full Text] [Related]
17. First on-line survey of an international multidisciplinary working group (MightyMedic) on current practice in diagnosis, therapy and follow-up of dyslipidemias.
Stefanutti C; D'Alessandri G; Petta A; Harada-Shiba M; Julius U; Soran H; Moriarty PM; Romeo S; Drogari E; Jaeger BR;
Atheroscler Suppl; 2015 May; 18():241-50. PubMed ID: 25936332
[TBL] [Abstract][Full Text] [Related]
18. Assessment of cardiovascular risk factors after renal transplantation: a step towards reducing graft failure.
Kumar R; Brar J; Yacoub R; Khan T; Zachariah M; Venuto R
Transplant Proc; 2012 Jun; 44(5):1270-4. PubMed ID: 22663999
[TBL] [Abstract][Full Text] [Related]
19. Assessing variability in compliance with recommendations given by the International Diabetes Federation (IDF) for patients with type 2 diabetes in primary care using electronic records. The APNA study.
Brugos-Larumbe A; Aldaz-Herce P; Guillen-Grima F; Garjón-Parra FJ; Bartolomé-Resano FJ; Arizaleta-Beloqui MT; Pérez-Ciordia I; Fernández-Navascués AM; Lerena-Rivas MJ; Berjón-Reyero J; Jusué-Rípodas L; Aguinaga-Ontoso I
Prim Care Diabetes; 2018 Feb; 12(1):34-44. PubMed ID: 28732655
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular risk management in type 2 diabetes of more than 10-year duration: Results of Polish ARETAEUS2-Grupa Study.
Leśniak W; Bała MM; Płaczkiewicz-Jankowska E; Topór-Mądry R; Jankowski M; Sieradzki J; Banasiak W;
Cardiol J; 2015; 22(2):150-9. PubMed ID: 25299503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
